| Spironolactone for heart failure with preserved ejection fraction B Pitt, MA Pfeffer, SF Assmann, R Boineau, IS Anand, B Claggett, ... New England Journal of Medicine 370 (15), 1383-1392, 2014 | 2763 | 2014 |
| Contemporary management of cardiogenic shock: a scientific statement from the American Heart Association S Van Diepen, JN Katz, NM Albert, TD Henry, AK Jacobs, NK Kapur, ... Circulation 136 (16), e232-e268, 2017 | 1477 | 2017 |
| Regional variation in patients and outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) trial MA Pfeffer, B Claggett, SF Assmann, R Boineau, IS Anand, N Clausell, ... Circulation 131 (1), 34-42, 2015 | 998 | 2015 |
| Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction SD Solomon, B Claggett, EF Lewis, A Desai, I Anand, NK Sweitzer, ... European heart journal 37 (5), 455-462, 2016 | 577 | 2016 |
| High-sensitivity ST2 for prediction of adverse outcomes in chronic heart failure B Ky, B French, K McCloskey, JE Rame, E McIntosh, P Shahi, DL Dries, ... Circulation: heart failure 4 (2), 180-187, 2011 | 528 | 2011 |
| Assessment of diastolic function with Doppler tissue imaging to predict genotype in preclinical hypertrophic cardiomyopathy CY Ho, NK Sweitzer, B McDonough, BJ Maron, SA Casey, JG Seidman, ... Circulation 105 (25), 2992-2997, 2002 | 495 | 2002 |
| Prognostic importance of impaired systolic function in heart failure with preserved ejection fraction and the impact of spironolactone AM Shah, B Claggett, NK Sweitzer, SJ Shah, IS Anand, L Liu, B Pitt, ... Circulation 132 (5), 402-414, 2015 | 481 | 2015 |
| Sacubitril/valsartan across the spectrum of ejection fraction in heart failure SD Solomon, M Vaduganathan, B L. Claggett, M Packer, M Zile, ... Circulation 141 (5), 352-361, 2020 | 471 | 2020 |
| Prognostic impact of diabetes mellitus in patients with heart failure according to the etiology of left ventricular systolic dysfunction DL Dries, NK Sweitzer, MH Drazner, LW Stevenson, BJ Gersh Journal of the American College of Cardiology 38 (2), 421-428, 2001 | 397 | 2001 |
| Advanced (stage D) heart failure: a statement from the Heart Failure Society of America Guidelines Committee JC Fang, GA Ewald, LA Allen, J Butler, CAW Canary, M Colvin-Adams, ... Journal of cardiac failure 21 (6), 519-534, 2015 | 372 | 2015 |
| Effects of sacubitril-valsartan versus valsartan in women compared with men with heart failure and preserved ejection fraction: insights from PARAGON-HF JJV McMurray, AM Jackson, CSP Lam, MM Redfield, IS Anand, J Ge, ... Circulation 141 (5), 338-351, 2020 | 366 | 2020 |
| Heart failure with recovered ejection fraction: clinical description, biomarkers, and outcomes A Basuray, B French, B Ky, E Vorovich, C Olt, NK Sweitzer, TP Cappola, ... Circulation 129 (23), 2380-2387, 2014 | 328 | 2014 |
| Cardiac structure and function in heart failure with preserved ejection fraction: baseline findings from the echocardiographic study of the Treatment of Preserved Cardiac … AM Shah, SJ Shah, IS Anand, NK Sweitzer, E O’Meara, JF Heitner, ... Circulation: Heart Failure 7 (1), 104-115, 2014 | 311 | 2014 |
| Prognostic relevance of left atrial dysfunction in heart failure with preserved ejection fraction ABS Santos, GQ Roca, B Claggett, NK Sweitzer, SJ Shah, IS Anand, ... Circulation: Heart Failure 9 (4), e002763, 2016 | 298 | 2016 |
| Cardiac structure and function and prognosis in heart failure with preserved ejection fraction: findings from the echocardiographic study of the Treatment of Preserved Cardiac … AM Shah, B Claggett, NK Sweitzer, SJ Shah, IS Anand, E O’Meara, ... Circulation: Heart Failure 7 (5), 740-751, 2014 | 282 | 2014 |
| Council on Cardiovascular and Stroke Nursing; Council on Quality of Care and Outcomes Research; and Mission: Lifeline. Contemporary management of cardiogenic shock: a … S van Diepen, JN Katz, NM Albert, TD Henry, AK Jacobs, NK Kapur, ... Circulation 136 (16), e232-e268, 2017 | 278 | 2017 |
| Ventricular-arterial coupling, remodeling, and prognosis in chronic heart failure B Ky, B French, A May Khan, T Plappert, A Wang, JA Chirinos, JC Fang, ... Journal of the American College of Cardiology 62 (13), 1165-1172, 2013 | 276 | 2013 |
| Multiple biomarkers for risk prediction in chronic heart failure B Ky, B French, WC Levy, NK Sweitzer, JC Fang, AHB Wu, LR Goldberg, ... Circulation: Heart Failure 5 (2), 183-190, 2012 | 273 | 2012 |
| Continuation versus discontinuation of renin–angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial JB Cohen, TC Hanff, P William, N Sweitzer, NR Rosado-Santander, ... The lancet respiratory medicine 9 (3), 275-284, 2021 | 241 | 2021 |
| SARS-CoV-2 infection and cardiovascular disease: COVID-19 heart BP Dhakal, NK Sweitzer, JH Indik, D Acharya, P William Heart, lung and Circulation 29 (7), 973-987, 2020 | 217 | 2020 |
